Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism New search for studies and content updated (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors versus Conventional Anticoagulants for the Treatment of Pulmonary Embolism New Search for Studies and Content Updated (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434234/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 03 June 2023.
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism New search for studies and content updated (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed June 3, 2023.
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism New search for studies and content updated (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors versus Conventional Anticoagulants for the Treatment of Pulmonary Embolism New Search for Studies and Content Updated (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism New search for studies and content updated (no change to conclusions)
ID - 434234
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434234/all/Oral_direct_thrombin_inhibitors_or_oral_factor_Xa_inhibitors versus_conventional_anticoagulants_for_the_treatment_of_pulmonary_embolism_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -